Barrier Enhancement for Eczema Prevention

NACompletedINTERVENTIONAL
Enrollment

1,394

Participants

Timeline

Start Date

November 1, 2014

Primary Completion Date

December 1, 2018

Study Completion Date

January 1, 2022

Conditions
Eczema
Interventions
OTHER

Experimental (Doublebase Gel® or Diprobase Cream®)

Emollient (Doublebase Gel® or Diprobase Cream®) use on the skin. The emollient should be applied at least once a day.

OTHER

Best practice skin care advice booklet

This is a booklet containing advice on best practice skin care. This will contain information on avoiding soap etc.

Trial Locations (16)

Unknown

School of Social and Community Medicine, University of Bristol, Bristol

Queens Hospital, Burton

Derby Childrens Hosptia, Derby

Harrogate District Hospital, Harrogate

Leicester Royal Infirmary, Leicester

Clapham Park Group Practice, London

Francis Grove Medical Practice, London

Park Group Practice, London

St John's Institute of Dermatology, London

St Mary's Hospital, London

Streatham Common Medical Practice, London

Nottingham University Hospitals NHS Trust, Nottingham

St Mary's Hospital, Portsmouth

Academic Unit of Dermatology Research, Univeristy of Sheffield, Sheffield

Kings Mill Hospital, Sutton in Ashfield

York Hospital, York

All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

University of Nottingham

OTHER

NCT04680520 - Barrier Enhancement for Eczema Prevention | Biotech Hunter | Biotech Hunter